{
  "Q0": "Whole Exome Sequencing (WES)",
  "Q1": "Yes",
  "Q2": "No",
  "Q3": "No",
  "Q4": "Yes",
  "Q4_followup": {
    "guideline_match": "No",
    "guideline": "ACMG"
  },
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_followup": {
    "alternative_test": "Chromosomal microarray analysis (CMA)"
  },
  "Q9": "Not specified",
  "Q10": "No",
  "Q10_followup": [
    "Diagnostic"
  ],
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14_followup": {
    "CPT_code": "81415"
  },
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires that the patient be evaluated by a clinician with expertise in clinical genetics and that genetic counseling be provided. Additionally, the policy specifies that chromosomal microarray analysis should be considered first-line testing for developmental delay. The claim should include documentation of these steps and any prior testing results.",
  "match": false
}